Aggressive resection of frequent peritoneal recurrences in colorectal cancer contributes to long-term survival.

about

Aggressive resection of frequent peritoneal recurrences in colorectal cancer contributes to long-term survival.

Item

http://www.wikidata.org/entity/Q42351654

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Aggressive resection of freque ...... ributes to long-term survival.

@en

Aggressive resection of freque ...... ributes to long-term survival.

@nl

type

Item

label

Aggressive resection of freque ...... ributes to long-term survival.

@en

Aggressive resection of freque ...... ributes to long-term survival.

@nl

prefLabel

Aggressive resection of freque ...... ributes to long-term survival.

@en

Aggressive resection of freque ...... ributes to long-term survival.

@nl

P1476

Aggressive resection of freque ...... ributes to long-term survival.

@en

P2093

Akira Ouchi

http://www.w3.org/2001/XMLSchema#string

Daisuke Hayashi

http://www.w3.org/2001/XMLSchema#string

Hideharu Tanaka

http://www.w3.org/2001/XMLSchema#string

Itaru Shigeyoshi

http://www.w3.org/2001/XMLSchema#string

Jiro Kawakami

http://www.w3.org/2001/XMLSchema#string

Kazunari Misawa

http://www.w3.org/2001/XMLSchema#string

Koji Komori

http://www.w3.org/2001/XMLSchema#string

Masayuki Tsutsuyama

http://www.w3.org/2001/XMLSchema#string

Norihisa Uemura

http://www.w3.org/2001/XMLSchema#string

Oshiro Taihei

http://www.w3.org/2001/XMLSchema#string

P2860

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer

A phase II clinical study of mFOLFOX6 plus bevacizumab as first-line therapy for Japanese advanced/recurrent colorectal cancer patients

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.

Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies.

Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: f

[A case report of advanced mucinous adenocarcinoma of the transverse colon with peritoneal dissemination effectively treated by multidisciplinary approach with a focus on FOLFOX4 therapy combined with panitumumab].

P304

501-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.18999/NAGJMS.78.4.501

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28008206

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5159476

http://www.w3.org/2001/XMLSchema#string